An interview with Novo Nordisk’s Irish boss – The Irish Times
Dilek Dogan Gurluk wants to know what Irish summers are like. The new general manager of Novo Nordisk’s…
India’s coming Ozempic moment could reshape both waistlines and perceptions
On a recent episode of CBS Sports Golazo, Clint Dempsey couldn’t resist a dig. Sitting alongside Thierry Henry,…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
Weight-loss drugs could alleviate anxiety and depression symptoms
Drugs such as Ozempic and Wegovy may be able to help alleviate symptoms of anxiety and depression, a…
Gabriel Iglesias Says It’s ‘Scary’ How He ‘Immediately Gained Back 20 Pounds’ After Quitting Ozempic
Gabriel IglesiasCredit: Gary Miller/Getty NEED TO KNOW Gabriel Iglesias shared his experience with Ozempic, saying it curbed his…
Is the ‘Ozempic era’ an opportunity for no-and-low?
With growing research to suggest GLP-1 drugs reduce the desire to drink alcohol, Eloise Feilden asks whether the…
What to Know about the Experimental GLP-1 Drug CagriSema
3 min read THESE DAYS, WHEN it comes to weight loss drugs, you’ve got a veritable buffet of…
I used to be a happy drunk — Ozempic made me a sad one
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Oscars 2026 Sparks Ozempic Debate Over Hollywood Weight-Loss Trend
Years after advocating for body positivity, at the Oscars this year, there was a return to the ‘heroin…
I’m 67, microdosing Ozempic and having the best sex of my life — and people think I’m in my 20s
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…